Revvityブログ
発見から治療までのイノベーションを促進
 
     
    
            
        Latest
      
    
    Optimizing functional genomics research tools by aligning their design with the ongoing evolution of the genome.
Functional Genomic Screening 
October 30, 2025  -  3  min read
       
      Small Molecule Drug Discovery
        Impact of FGFRs dysregulation in oncogenic mechanisms.
            June 6, 2024 -
            4 min read
          
          
         
      Small Molecule Drug Discovery
        Disrupting protein-protein interactions in the viral life cycle: the contribution of tr-FRET.
            June 6, 2024 -
            3 min read
          
          
         
      Small Molecule Drug Discovery
        Deciphering TREM2’s role in Alzheimer’s disease.
            June 6, 2024 -
            4 min read
          
          
         
      Small Molecule Drug Discovery
        Strategies for success: Developing safe and effective commercial cell lines.
            June 6, 2024 -
            2 min read
          
          
         
      Small Molecule Drug Discovery
        When AlphaLISA and HTRF meet inflammatory bowel disease research needs.
            June 5, 2024 -
            4 min read
          
          
         
      Disease Research
        The potential of subset-specific treatment options to overcome cancer resistance.
            June 4, 2024 -
            2 min read
          
          
         
       
      Small Molecule Drug Discovery
        3 steps for successful tumor xenograft analysis.
            June 3, 2024 -
            3 min read
          
          
         
      Cell and Gene Therapy, Biologics, Small Molecule Drug Discovery
        The evolving role of cell counting in drug discovery.
            May 30, 2024 -
            2 min read
          
          
         
      Drug Development
        Drug repurposing for antiviral therapies: research and strategies with high throughput screening.
            May 29, 2024 -
            2 min read
          
          
         
                   
                   
                   
                   
                   
                   
                   
                   
                   
                   
                   
                   
                   
                   
                   
                   
                   
                   
                   
                   
                   
                   
                   
                   
                   
                   
                   
                  